Arkolith/Insider Trading/RVMD/Form 4

Mancini Anthony

See RemarksRevolution Medicines, Inc. (RVMD) · full profile →Form 4 · filed Mar 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.6M
Net Open-Market Flow
-$3.6M
Transactions
7
6 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 25, 2026Sell(S)400$97.21$39K54K
Mar 25, 2026Sell(S)11K$96.43$1.1M55K
Mar 25, 2026Sell(S)21K$95.49$2.0M66K
Mar 25, 2026Sell(S)3K$94.16$295K87K
Mar 25, 2026Sell(S)2K$93.22$168K90K
Mar 25, 2026Option exercise(M)37K$33.62$1.3M92K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 25, 2026Option exercise(M)37K—$0112K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-26-000137) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML